Uncommon hematologic malignancies. Case 3. Parotid swelling during treatment for transformed mycosis fungoides.
Bird
Brian R
BR
St. James's Hospital and Trinity College, Dublin, Ireland.
Daly
Peter A
PA
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D001761:Bleomycin / Q000009:adverse effects*; D002471:Cell Transformation, Neoplastic; D003520:Cyclophosphamide / Q000009:adverse effects*; D003920:Diabetes Mellitus / Q000139:chemically induced; D004317:Doxorubicin / Q000009:adverse effects*; D006801:Humans; D015228:Hypertriglyceridemia / Q000139:chemically induced; D007333:Insulin Resistance; D002955:Leucovorin / Q000009:adverse effects*; D008060:Lipodystrophy / Q000139:chemically induced*; D008279:Magnetic Resonance Imaging; D008297:Male; D008727:Methotrexate / Q000009:adverse effects*; D008875:Middle Aged; D009182:Mycosis Fungoides / Q000188:drug therapy*; D010305:Parotid Diseases / Q000139:chemically induced* / Q000175:diagnosis; D010306:Parotid Gland / Q000473:pathology; D011241:Prednisone / Q000009:adverse effects*; D012878:Skin Neoplasms / Q000188:drug therapy*; D014750:Vincristine / Q000009:adverse effects*
D001761:Bleomycin; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D002955:Leucovorin; D011241:Prednisone; D008727:Methotrexate